Drug Research
German CDMO Acquired By London Team Of Great Point Partners
On a mission so as to debut the life sciences companies on an international stage, Great Point Partners, the healthcare investment firm, is making a play in terms of a private German contract development and manufacturing organization, Lyocontract.
Great Point...
Drug Research
Prefilled Syringes Segment Is Eyeing More Acceptability
Prefilled syringes have gone on to make up a decent portion in terms of injectable packaging segment in the past 10 years. As per an analysis done by GloblData, PFS went on to get 17% of the US FDA...
Drug Research
The Prefilled Biologics Universe And Its Progressive Outlook
It is well to be noted that prefilled products, specifically prefilled biologics, happen to be a growing segment in the pharmaceutical sector. Prefilled syringes as well as pens offer detailed dosing, thereby decreasing the error risk in the process...
Drug Research
Injectable Drug Delivery Market To Grow At A CAGR of 9%
A new report rolled out by MarketsandMarkets has gone on to forecast that the injectable drug delivery market is going to be reaching almost 9% CAGR between 2024 and 2029.
This market is expected to be valued at $1139 billion...
Drug Research
APAC Bioclusters A Standout In Biopharmaceutical Innovation
Worldwide pharmaceutical companies look to advance the development of molecules from the laboratory to the clinic and then market them as soon as possible. All this must go on to unfold sans sacrificing the quality of the product, efficiency...
Drug Research
Q1 of 2024 Witnesses New Highs In Biopharmaceutical M&A
It has indeed been a roller coaster ride for the biopharmaceutical sector ever since the pandemic-led surge in 2020. Since 2023, the resurgence when it comes to mergers and acquisitions has also gone on to signal a significant uptick...
Drug Research
Global Biopharmaceutical Market To Reach New Heights By 2032
The worldwide biopharmaceutical market is all set to have prominent growth, with the value anticipated to reach $566 billion by 2032, which is up from $263 billion in 2022, thereby reflecting a CAGR of almost 8% from 2023 to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
